Coronary artery spasm induced by 5-fluorouracil

Zeitschrift fur Kardiologie

Volumn 94, Issue 1, 2005, Pages 33-37

  Alter, P ^a   Herzum, M ^a   Schaefer, J R ^a   Maisch, B ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

5 fluorouracil; Angina pectoris; Cardiotoxicity; Coronary vasospasm

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID; NITRATE; VERAPAMIL;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CASE REPORT; CORONARY ARTERY SPASM; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ESOPHAGEAL ADENOCARCINOMA; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; PATHOPHYSIOLOGY; SPASMOPHILIA; SUDDEN DEATH;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VASOSPASM; ELECTROCARDIOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; EXERCISE TEST; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; NEOADJUVANT THERAPY; REGIONAL BLOOD FLOW;

EID: 13244269992     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0159-8     Document Type: Article

References (23)

1. Lestuzzi C, Viel E, Picano E, Meneguzzo N (2001) Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil. Am J Med 111(4):316-318
2. Maseri A, Lanza G (2001) Fluorouracil-induced coronary artery spasm. Am J Med 111(4):326-327
3. Freeman NJ, Costanza ME (1988) 5-Fluorouracil-associated cardiotoxicity. Cancer 61(1):36-45
4. De Forni M, Malet-Martino MC, Jaillais P, Shubinski RE, Bachaud JM, Lemaire L et al (1992) Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 10(11):1795-1801
5. Schober C, Papageorgiou E, Harstrick A, Bokemeyer C, Mugge A, Stahl M et al (1993) Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer 72(7):2242-2247
6. Anand AJ (1994) Fluorouracil cardiotoxicity. Ann Pharmacother 28(3):374-378
7. Rezkalla S, Kloner RA, Ensley J, al Sarraf M, Revels S, Olivenstein A et al (1989) Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 7(4):509-514
8. Robben NC, Pippas AW, Moore JO (1993) The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy. Cancer 71(2):493-509
9. Tsavaris N, Kosmas C, Vadiaka M, Efremidis M, Zinelis A, Beldecos D et al (2002) Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy - a survey of 427 patients. Med Sci Monit 8(6):I51-I57
10. Becker K, Erckenbrecht JF, Haussinger D, Frieling T (1999) Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 57(4):475-484
11. Dent RG, McColl I (1975) Letter: 5-Fluorouracil and angina. Lancet 1(7902):347-348
12. Baker WP, Dainer P, Lester WM, Marty AM, Blair TP (1986) Ischemic chest pain after 5-fluorouracil therapy for cancer. Am J Cardiol 57(6):497-498
13. Weidmann B, Jansen W, Heider A, Niederle N (1995) 5-Fluorouracil cardiotoxicity with left ventricular dysfunction under different dosing regimens. Am J Cardiol 75(2):194-195
14. Kuropkat C, Griem K, Clark J, Rodriguez ER, Hutchinson J, Taylor SG (1999) Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report. Am J Clin Oncol 22(5):466-470
15. Lemaire L, Malet-Martino MC, Longo S, Martino R, De Forni M, Carton M (1991) Fluoroacetaldehyde as cardiotoxic impurity in fluorouracil (Roche). Lancet 337(8740):560
16. Lieutaud T, Brain E, Golgran-Toledano D, Vincent F, Cvitkovic E, Leclercq B et al (1996) 5-Fluorouracil cardiotoxicity: a unique mechanism for ischaemic cardiopathy and cardiac failure? Eur J Cancer 32A(2):368-369
17. De Forni M, Armand JP (1994) Cardiotoxicity of chemotherapy. Curr Opin Oncol 6(4):340-344
18. Baerlocher GM, Beer JH, Owen GR, Meiselman HJ, Reinhart WH (1997) The anti-neoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology. Br J Haematol 99(2):426-432
19. Mosseri M, Fingert HJ, Varticovski L, Chokshi S, Isner JM (1993) In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 53(13):3028-3033
20. Ensley JF, Patel B, Kloner R, Kish JA, Wynne J, al Sarraf M (1989) The clinical syndrome of 5-fluorouracil cardiotoxicity. Invest New Drugs 7(1):101-109
21. Rozenman Y, Gurewich J, Gotsman MS (1995) Myocardial ischemia induced by topical use of 5-fluorouracu. Int J Cardiol 49(3):282-283
22. Abernethy DR, Schwartz JB (1999) Calcium-antagonist drugs. N Engl J Med 341(19):1447-1457
23. Oleksowicz L, Bruckner HW (1988) Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers. Am J Med 85(5):750-751